Latest filing published 12 Aug 2026 for AMGEN INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Matthew C. Busch discloses dealings in Amgen Inc to SEC (Form 4). We count 23 filings; the first trade dates from 5 November 2023 and the latest from 7 August 2026.
The open-market record consists of 2 sales worth €566k, with no purchase. The rest of the record consists of 21 share grants. In 2026 alone, the filings show no purchases and 1 sale.
The latest filing, published on 12 August 2026, reports a share grant in Amgen Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations